vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and Capitol Federal Financial, Inc. (CFFN). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $57.7M, roughly 1.2× Capitol Federal Financial, Inc.). Capitol Federal Financial, Inc. runs the higher net margin — 34.9% vs 4.7%, a 30.2% gap on every dollar of revenue. Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 12.1%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
Capitol Federal Savings Bank (CapFed) is a federally chartered and insured savings bank founded in 1893 and headquartered in Topeka, Kansas. Capitol Federal has 51 locations serving both the Kansas and Missouri sides of the Kansas City metropolitan area with personal and business financial services. It is owned by holding company Capitol Federal Financial Inc. for trading on the Nasdaq.
ADPT vs CFFN — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $57.7M |
| Net Profit | $3.4M | $20.1M |
| Gross Margin | 73.6% | — |
| Operating Margin | -27.1% | — |
| Net Margin | 4.7% | 34.9% |
| Revenue YoY | 35.1% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | $57.7M | ||
| Q4 25 | $71.7M | $56.8M | ||
| Q3 25 | $94.0M | $54.6M | ||
| Q2 25 | $58.9M | $50.7M | ||
| Q1 25 | $52.4M | $48.8M | ||
| Q4 24 | $47.5M | $46.9M | ||
| Q3 24 | $46.4M | — | ||
| Q2 24 | $43.2M | $45.0M |
| Q1 26 | $3.4M | $20.1M | ||
| Q4 25 | $-13.6M | $20.3M | ||
| Q3 25 | $9.5M | $18.8M | ||
| Q2 25 | $-25.6M | $18.4M | ||
| Q1 25 | $-29.9M | $15.4M | ||
| Q4 24 | $-33.7M | $15.4M | ||
| Q3 24 | $-32.1M | — | ||
| Q2 24 | $-46.2M | $9.6M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — |
| Q1 26 | -27.1% | — | ||
| Q4 25 | -17.8% | 44.4% | ||
| Q3 25 | 10.9% | 42.2% | ||
| Q2 25 | -42.5% | 42.6% | ||
| Q1 25 | -56.4% | 39.5% | ||
| Q4 24 | -71.3% | 40.7% | ||
| Q3 24 | -70.3% | — | ||
| Q2 24 | -109.6% | 34.7% |
| Q1 26 | 4.7% | 34.9% | ||
| Q4 25 | -18.9% | 35.7% | ||
| Q3 25 | 10.2% | 34.5% | ||
| Q2 25 | -43.5% | 36.2% | ||
| Q1 25 | -56.9% | 31.6% | ||
| Q4 24 | -71.0% | 32.9% | ||
| Q3 24 | -69.1% | — | ||
| Q2 24 | -107.0% | 21.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.08 | $0.16 | ||
| Q3 25 | $0.06 | $0.14 | ||
| Q2 25 | $-0.17 | $0.14 | ||
| Q1 25 | $-0.20 | $0.12 | ||
| Q4 24 | $-0.22 | $0.12 | ||
| Q3 24 | $-0.22 | — | ||
| Q2 24 | $-0.31 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | $2.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.0B |
| Total Assets | $505.9M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | $2.5M | ||
| Q4 25 | $70.5M | $232.6M | ||
| Q3 25 | $55.0M | $252.4M | ||
| Q2 25 | $43.2M | $175.0M | ||
| Q1 25 | $50.6M | $340.4M | ||
| Q4 24 | $47.9M | $170.3M | ||
| Q3 24 | $38.1M | — | ||
| Q2 24 | $59.8M | $317.8M |
| Q1 26 | — | $1.0B | ||
| Q4 25 | $218.8M | $1.0B | ||
| Q3 25 | $204.4M | $1.0B | ||
| Q2 25 | $179.7M | $1.0B | ||
| Q1 25 | $190.4M | $1.0B | ||
| Q4 24 | $202.7M | $1.0B | ||
| Q3 24 | $223.8M | — | ||
| Q2 24 | $241.6M | $1.0B |
| Q1 26 | $505.9M | $9.8B | ||
| Q4 25 | $512.7M | $9.8B | ||
| Q3 25 | $490.6M | $9.8B | ||
| Q2 25 | $496.6M | $9.7B | ||
| Q1 25 | $510.9M | $9.7B | ||
| Q4 24 | $539.4M | $9.5B | ||
| Q3 24 | $558.5M | — | ||
| Q2 24 | $584.9M | $9.6B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADPT
Segment breakdown not available.
CFFN
| Net Interest Income | $52.3M | 91% |
| Noninterest Income | $5.5M | 9% |
